Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-12-15
|
pubmed:abstractText |
This multicentre, double-blind, randomized, placebo-controlled, parallel study was designed to evaluate the efficacy of combined oral lysine acetylsalicylate and metoclopramide (LAS-MCP) in the acute treatment of migraine attacks. A total of 266 patients, 18-65 years old, with two to six attacks of migraine with or without aura (IHS criteria) per month were included. The patients had to treat two migraine attacks with LAS-MCP (1620 mg lysine acetylsalicylate--the equivalent of 900 mg aspirin--combined with 10 mg metoclopramide) or placebo. The main outcome measure was headache relief (reduction in headache severity from grade 3 or 2--severe or moderate--to grade 1 or 0--mild or none) 2 h after treatment. LAS-MCP was superior to placebo for headache relief (56% vs 28%) and for the following secondary outcome measures: complete headache relief (18% vs 7%; p < 0.001), nausea (28% vs 44%; p < 0.001), vomiting (3% vs 11%; p = 0.001), use of rescue medication (47% vs 68%; p < 0.001), global efficacy judged as good or excellent (32% vs 14%; p < 0.001). The tolerability was considered as good in 94% of treated attacks in both groups. Combined oral lysine acetylsalicylate and metoclopramide is an effective and well-tolerated acute treatment of migraine attacks.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Lysine,
http://linkedlifedata.com/resource/pubmed/chemical/Metoclopramide,
http://linkedlifedata.com/resource/pubmed/chemical/acetylsalicylic acid lysinate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0333-1024
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
297-300
|
pubmed:dateRevised |
2008-2-11
|
pubmed:meshHeading |
pubmed-meshheading:7954760-Administration, Oral,
pubmed-meshheading:7954760-Adult,
pubmed-meshheading:7954760-Analgesics,
pubmed-meshheading:7954760-Aspirin,
pubmed-meshheading:7954760-Double-Blind Method,
pubmed-meshheading:7954760-Drug Therapy, Combination,
pubmed-meshheading:7954760-Female,
pubmed-meshheading:7954760-Humans,
pubmed-meshheading:7954760-Lysine,
pubmed-meshheading:7954760-Male,
pubmed-meshheading:7954760-Metoclopramide,
pubmed-meshheading:7954760-Middle Aged,
pubmed-meshheading:7954760-Migraine Disorders
|
pubmed:year |
1994
|
pubmed:articleTitle |
Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study.
|
pubmed:affiliation |
Service de Neurologie, Hôpital Saint Antoine, Paris, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|